Home / Health / Airlines Wrestle With Drug Tests for Pilots
Airlines Wrestle With Drug Tests for Pilots
10 Aug
Summary
- Airlines face challenges detecting psychoactive substance use by flight crew.
- Random dope testing is seen as the primary deterrent for crew drug use.
- DGCA rules require 10% of flight crew to be tested annually for substances.
The evolving legal status of marijuana in various global locations presents significant challenges for airlines in detecting the use of psychoactive substances by their flight crews. Unlike simple breathalyzer tests for alcohol, identifying drug consumption is more intricate and often requires longer detection windows.
Airlines worldwide are concerned about the safety implications of crew members operating flights while under the influence of any psychoactive substance, as mandated by the International Civil Aviation Organization. This concern is underscored by incidents involving pilots whose judgment may have been impaired by recent drug use.
To address this, officials suggest an increase in random drug testing as the most effective deterrent. Current regulations by the Directorate General of Civil Aviation (DGCA) require scheduled airlines and air navigation service providers to test at least 10% of their flight crew and air traffic controllers annually.
While airlines promote awareness and voluntary self-reporting for addiction, these initiatives have seen limited success. The focus remains on deterring consumption through stricter consequences and enhanced random testing measures to ensure flight safety.
